Pleural Tuberculosis in a Patient After COVID-19 Pneumonia

Basit Öğe Kaydı
dc.contributor.authorAlkan, Sevil
dc.contributor.authorDindar Demiray, Emine Kübra
dc.contributor.authorDurgun, Mehmet
dc.contributor.authorPaşa, Özgür
dc.contributor.authorSefer, Sinem
dc.date.accessioned2025-05-29T05:21:21Z
dc.date.available2025-05-29T05:21:21Z
dc.date.issued2022
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractDuring the coronavirus disease 2019 (COVID-19) pandemic, it was observed that the clinics of existing and undiagnosed tuberculosis (TB) patients were more severe, especially in low and middle-income countries where TB is endemic and there is a lack of healthcare. There is limited literature on whether the coexistence of TB and COVID 19 or the lung damage/immune state caused by COVID-19, or whether immunosuppressive therapies used during the treatment of COVID-19 whether it creates a predisposition to TB. In this case report, we aimed to present a 66-year-old female patient diagnosed as pleural tuberculosis after COVID-19 pneumonia and to examine the possible relationship between COVID-19 and TB.
dc.identifier.doi10.19127/bshealthscience.944827
dc.identifier.endpage103
dc.identifier.issn2619-9041
dc.identifier.issue1
dc.identifier.startpage101
dc.identifier.urihttps://doi.org/10.19127/bshealthscience.944827
dc.identifier.urihttps://hdl.handle.net/20.500.12428/30593
dc.identifier.volume5
dc.language.isoen
dc.publisherCem TIRINK
dc.relation.ispartofBlack Sea Journal of Health Science
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_DergiPark_20250529
dc.subjectCOVID 19
dc.subjectPleural tuberculosis
dc.subjectTuberculosis
dc.subjectEmpyema
dc.titlePleural Tuberculosis in a Patient After COVID-19 Pneumonia
dc.typeArticle

Dosyalar

Koleksiyon

DergiPark